New

Recombinant factor VIII Market

2021

Recombinant factor VIII Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (200IU, 250IU); Application (Hospital, Pharmacy) and Geography

| Report Code: TIPRE00020858 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Recombinant factor VIII Market 2028 By Type, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Factor VIII (FVIII) is a crucial blood- coagulating protein, also called anti-hemophilic factor (AHF) and is encoded by F8 gene. Default in which results in hemophilia A. Recombinant Factor VIII is a kind of medication which is a replacement therapy with recombinant factor VIII (rFVIII) that is utilized to treat and prevent bleeding in people with hemophilia A or other reasons of low factor VIII. Certain preparations may likewise be utilized in those with von Willebrand's disease. It is given by slow injection into the vein.

MARKET DYNAMICS

The recombinant factor VIII market is anticipated to achieve substantial growth by the end of the forecasted period. Rise in number of people suffering from hemophilia will enhance the recombinant factor VIII market growth in the near future. Additionally, the improved healthcare facilities in developed economies are also expected to boost market growth. However, high investment, R&D and marketing needed for it, may serve as market growth restraining factors.

MARKET SCOPE

The "Recombinant factor VIII market analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of recombinant factor VIII market with detailed market segmentation by type and application. The recombinant factor VIII market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in recombinant factor VIII market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The recombinant factor VIII market are segmented on the basis of type and application. On the basis of type, the market is segmented into 200IU and 250IU. On the basis of application, the market is segmented as hospital and pharmacy.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the recombinant factor VIII market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant factor VIII market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting recombinant factor VIII market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the recombinant factor VIII market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the recombinant factor VIII market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from recombinant factor VIII market are anticipated to have lucrative growth opportunities in the future with the rising demand for recombinant factor VIII in the global market. Below mentioned is the list of few companies engaged in the recombinant factor VIII market.

The report also includes the profiles of key players in recombinant factor VIII market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Bayer
  •  CSL Behring
  •  Shire (Baxter)
  •  Pfizer
  •  Octapharma
  •  Biogen
  •  Novo Nordisk
  •  Grifols
  •  ProSpec
  •  BPL Group

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Factor VIII Market - By Type
1.3.2 Recombinant Factor VIII Market - By Application
1.3.3 Recombinant Factor VIII Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. RECOMBINANT FACTOR VIII MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. RECOMBINANT FACTOR VIII MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. RECOMBINANT FACTOR VIII MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT FACTOR VIII - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT FACTOR VIII - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. RECOMBINANT FACTOR VIII MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 200IU
7.3.1. Overview
7.3.2. 200IU Market Forecast and Analysis
7.4. 250IU
7.4.1. Overview
7.4.2. 250IU Market Forecast and Analysis
8. RECOMBINANT FACTOR VIII MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. PHARMACY
8.4.1. Overview
8.4.2. Pharmacy Market Forecast and Analysis

9. RECOMBINANT FACTOR VIII MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Recombinant Factor VIII Market Overview
9.1.2 North America Recombinant Factor VIII Market Forecasts and Analysis
9.1.3 North America Recombinant Factor VIII Market Forecasts and Analysis - By Type
9.1.4 North America Recombinant Factor VIII Market Forecasts and Analysis - By Application
9.1.5 North America Recombinant Factor VIII Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Recombinant Factor VIII Market
9.1.5.1.1 Canada Recombinant Factor VIII Market by Type
9.1.5.1.2 Canada Recombinant Factor VIII Market by Application
9.1.5.2 Mexico Recombinant Factor VIII Market
9.1.5.2.1 Mexico Recombinant Factor VIII Market by Type
9.1.5.2.2 Mexico Recombinant Factor VIII Market by Application
9.1.5.3 US Recombinant Factor VIII Market
9.1.5.3.1 US Recombinant Factor VIII Market by Type
9.1.5.3.2 US Recombinant Factor VIII Market by Application
9.2. EUROPE
9.2.1 Europe Recombinant Factor VIII Market Overview
9.2.2 Europe Recombinant Factor VIII Market Forecasts and Analysis
9.2.3 Europe Recombinant Factor VIII Market Forecasts and Analysis - By Type
9.2.4 Europe Recombinant Factor VIII Market Forecasts and Analysis - By Application
9.2.5 Europe Recombinant Factor VIII Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Recombinant Factor VIII Market
9.2.5.1.1 Germany Recombinant Factor VIII Market by Type
9.2.5.1.2 Germany Recombinant Factor VIII Market by Application
9.2.5.2 France Recombinant Factor VIII Market
9.2.5.2.1 France Recombinant Factor VIII Market by Type
9.2.5.2.2 France Recombinant Factor VIII Market by Application
9.2.5.3 Italy Recombinant Factor VIII Market
9.2.5.3.1 Italy Recombinant Factor VIII Market by Type
9.2.5.3.2 Italy Recombinant Factor VIII Market by Application
9.2.5.4 Spain Recombinant Factor VIII Market
9.2.5.4.1 Spain Recombinant Factor VIII Market by Type
9.2.5.4.2 Spain Recombinant Factor VIII Market by Application
9.2.5.5 United Kingdom Recombinant Factor VIII Market
9.2.5.5.1 United Kingdom Recombinant Factor VIII Market by Type
9.2.5.5.2 United Kingdom Recombinant Factor VIII Market by Application
9.2.5.6 Rest of Europe Recombinant Factor VIII Market
9.2.5.6.1 Rest of Europe Recombinant Factor VIII Market by Type
9.2.5.6.2 Rest of Europe Recombinant Factor VIII Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Recombinant Factor VIII Market Overview
9.3.2 Asia-Pacific Recombinant Factor VIII Market Forecasts and Analysis
9.3.3 Asia-Pacific Recombinant Factor VIII Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Recombinant Factor VIII Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Recombinant Factor VIII Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Recombinant Factor VIII Market
9.3.5.1.1 Australia Recombinant Factor VIII Market by Type
9.3.5.1.2 Australia Recombinant Factor VIII Market by Application
9.3.5.2 China Recombinant Factor VIII Market
9.3.5.2.1 China Recombinant Factor VIII Market by Type
9.3.5.2.2 China Recombinant Factor VIII Market by Application
9.3.5.3 India Recombinant Factor VIII Market
9.3.5.3.1 India Recombinant Factor VIII Market by Type
9.3.5.3.2 India Recombinant Factor VIII Market by Application
9.3.5.4 Japan Recombinant Factor VIII Market
9.3.5.4.1 Japan Recombinant Factor VIII Market by Type
9.3.5.4.2 Japan Recombinant Factor VIII Market by Application
9.3.5.5 South Korea Recombinant Factor VIII Market
9.3.5.5.1 South Korea Recombinant Factor VIII Market by Type
9.3.5.5.2 South Korea Recombinant Factor VIII Market by Application
9.3.5.6 Rest of Asia-Pacific Recombinant Factor VIII Market
9.3.5.6.1 Rest of Asia-Pacific Recombinant Factor VIII Market by Type
9.3.5.6.2 Rest of Asia-Pacific Recombinant Factor VIII Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Recombinant Factor VIII Market Overview
9.4.2 Middle East and Africa Recombinant Factor VIII Market Forecasts and Analysis
9.4.3 Middle East and Africa Recombinant Factor VIII Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Recombinant Factor VIII Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Recombinant Factor VIII Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Recombinant Factor VIII Market
9.4.5.1.1 South Africa Recombinant Factor VIII Market by Type
9.4.5.1.2 South Africa Recombinant Factor VIII Market by Application
9.4.5.2 Saudi Arabia Recombinant Factor VIII Market
9.4.5.2.1 Saudi Arabia Recombinant Factor VIII Market by Type
9.4.5.2.2 Saudi Arabia Recombinant Factor VIII Market by Application
9.4.5.3 U.A.E Recombinant Factor VIII Market
9.4.5.3.1 U.A.E Recombinant Factor VIII Market by Type
9.4.5.3.2 U.A.E Recombinant Factor VIII Market by Application
9.4.5.4 Rest of Middle East and Africa Recombinant Factor VIII Market
9.4.5.4.1 Rest of Middle East and Africa Recombinant Factor VIII Market by Type
9.4.5.4.2 Rest of Middle East and Africa Recombinant Factor VIII Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Recombinant Factor VIII Market Overview
9.5.2 South and Central America Recombinant Factor VIII Market Forecasts and Analysis
9.5.3 South and Central America Recombinant Factor VIII Market Forecasts and Analysis - By Type
9.5.4 South and Central America Recombinant Factor VIII Market Forecasts and Analysis - By Application
9.5.5 South and Central America Recombinant Factor VIII Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Recombinant Factor VIII Market
9.5.5.1.1 Brazil Recombinant Factor VIII Market by Type
9.5.5.1.2 Brazil Recombinant Factor VIII Market by Application
9.5.5.2 Argentina Recombinant Factor VIII Market
9.5.5.2.1 Argentina Recombinant Factor VIII Market by Type
9.5.5.2.2 Argentina Recombinant Factor VIII Market by Application
9.5.5.3 Rest of South and Central America Recombinant Factor VIII Market
9.5.5.3.1 Rest of South and Central America Recombinant Factor VIII Market by Type
9.5.5.3.2 Rest of South and Central America Recombinant Factor VIII Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. RECOMBINANT FACTOR VIII MARKET, KEY COMPANY PROFILES
11.1. BAYER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CSL BEHRING
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SHIRE(BAXTER)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. OCTAPHARMA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOGEN
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVO NORDISK
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GRIFOLS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PROSPEC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BPL GROUP
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer
2. CSL Behring
3. Shire(Baxter)
4. Pfizer
5. Octapharma
6. Biogen
7. Novo Nordisk
8. Grifols
9. ProSpec
10. BPL Group
TIPRE00020858
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.